[News Brief] Lynk Pharmaceuticals Doses First Patient in LNK01004 Vitiligo Trial
Lynk Pharmaceuticals Co., Ltd. has initiated dosing in its Phase II clinical trial evaluating LNK01004, a topical pan-JAK inhibitor, for…
Global Pharmaceuticals & Supplements
[News Brief] Senhwa Biosciences Secures NT$500 Million Share Purchase Agreement with GEM
Senhwa Biosciences, Inc. has entered into a share purchase agreement with GEM Global Yield LLC SCS and GEM Yield Bahamas…
[News Brief] Godavari Biorefineries Validates European Patent for Anti-Cancer Molecule
Godavari Biorefineries has announced the successful validation of its European patent for a novel anti-cancer molecule in Spain, the United…
[News Brief] DoH Abu Dhabi, AstraZeneca, and PureHealth Establish Rare Diseases Centre
The Department of Health – Abu Dhabi (DoH), AstraZeneca, and PureHealth have signed a Memorandum of Understanding (MoU) to activate…
[News Brief] Takeda and Indonesian Government Partner to Advance Plasma Healthcare
Takeda and the Indonesian Government have announced a multi-phased collaboration to strengthen the country’s plasma ecosystem and expand access to…
[News Brief] Bristol Myers Squibb Names Singapore as Pan Asia Hub
Bristol Myers Squibb (BMS) has recognised Singapore as its new Pan Asia Cluster (PAC) hub, supported by the Singapore Economic…
[News Brief] UCL and Eisai Extend Neurodegenerative Disease Research Partnership
University College London (UCL) and Eisai Co., Ltd. have signed a new agreement extending their collaboration in drug discovery and…
[News Brief] Cadila Pharmaceuticals and Wellesta Holdings Sign Joint Venture MoU
Cadila Pharmaceuticals and Wellesta Holdings have signed a memorandum of understanding to establish a strategic joint venture focused on commercialising…
[News Brief] Abbisko Expands R&D Collaboration with Eli Lilly
Abbisko Therapeutics has entered into a strategic research collaboration and licence agreement with Eli Lilly and Company to discover and…
[News Brief] Haisco Licenses Drug Candidates to Nuvectis
Haisco Pharmaceutical Group has entered into an exclusive licensing agreement with US-based biotechnology company Nuvectis for two internally developed clinical-stage…